The Neuro4D conference takes place in Mainz, Germany on May 15-16, 2023.

With a focus on drug discovery for proteopathic neurodegenerative diseases, the meeting brings together experts from discovery companies, service providers and academic innovators in the field of neurodegenerative diseases e.g. Alzheimer’s disease, Parkinson’s disease, FTD and ALS.

At the meeting, Lotta Agholme, Laboratory Operations Manager at Cellectricon, will give a presentation on:

Effects of partial reduction of amyloid-β production on synaptic function in vitro


If you are interested in learning more about the talk or Cellectricon’s drug discovery services, please reach out to us.

Visit event site